Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00549_DB01101> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00549_DB01101 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00549_DB01101 label "DDI between Zafirlukast and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if capecitabine is initiated, discontinued or dose changed. [drugbank_resource:DB00549_DB01101]" assertion.
- drugbank_resource:DB00549_DB01101 identifier "drugbank_resource:DB00549_DB01101" assertion.
- drugbank_resource:DB00549_DB01101 title "DDI between Zafirlukast and Capecitabine - Capecitabine, a strong CYP2C9 inhibitor, may decrease the metabolism and clearance of zafirlukast. Consider alternate therapy or monitor for changes in zafirlukast therapeutic and adverse effects if capecitabine is initiated, discontinued or dose changed." assertion.